![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61K 39/00 | (2013.01) | ||
C12N 5/00 | (2006.01) | ||
A61K2039/505 | (2013.01) | ||
C07K 17/14 | (2006.01) | ||
A61K 47/6889 | (2017.08) | ||
A61P 35/00 | (2006.01) | ||
A61K 47/6803 | (2017.08) | ||
A61K 47/00 | (2006.01) | ||
A61K 47/6849 | (2017.08) | ||
A61K 47/6867 | (2017.08) | ||
A61K 38/05 | (2013.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2018.01) |
(11) | Number of the document | 3545969 |
(13) | Kind of document | T |
(96) | European patent application number | 19159583.4 |
Date of filing the European patent application | 2010-01-08 | |
(97) | Date of publication of the European application | 2019-10-02 |
(45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
14371309 P | 2009-01-09 | US | |
15220509 P | 2009-02-12 | US | |
17571909 P | 2009-05-05 | US | |
26422209 P | 2009-11-24 | US |
(72) |
SIEVERS, Eric , US
KENNEDY, Dana , US
IHLE, Nathan , US
SUN, Michael , US
|
(73) |
Seagen Inc. ,
21823 30th Drive S.E., Bothell, WA 98021,
US
|
(54) | DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |
DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |